The characterization of these new Drosophila models of PD provides in vivo evidence that dominant mutations in VPS35 likely do not act via a dominant toxic gain of function but rather through a partial loss of function conferring an age-dependent haploinsufficiency. The gene discussed is VPS35; the disease is late-onset Parkinson disease.